HOWL FY 2020 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$41M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$777,000

Operating Income

-$22M

Net Income

-$15M

EPS (Diluted)

$-0.98

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$632,000

Balance Sheet

Total Assets

$96M

Total Liabilities

$7M

Stockholders' Equity

$89M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$777,000	-$463,000	-67.8%
Operating Income	-$22M	-$10M	-125.5%
Net Income	-$15M	-$11M	-35.9%